PV | RITUXAN® (rituximab) Dosing & Infusion Resources
Rituxan (Rituximab): Uses, Dosage, Side Effects, Interactions, Warning
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
Rituximab Biosimilar Truxima Now Available for Rheumatoid Arthritis - MPR
Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today
RA | RITUXAN® (rituximab) Infusions & Dosing Schedule
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis | NEJM
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
ePosters - A retrospective audit of reduced-dose rituximab in rheumatoid arthritis
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis | SpringerLink
Rituximab Infusion Dosing | RIABNI™ (rituximab-arrx)
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial - The Lancet Rheumatology
RA | RITUXAN® (rituximab) Infusion Steps & Resources
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
Ultra-Low Rituximab Dose in RA Fails to Meet Non-Inferiority
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
JCM | Free Full-Text | Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
PV | Taking & Dosing RITUXAN® (rituximab)
GPA & MPA | RITUXAN® (rituximab) Pediatric Dosing & Infusion Info
Should You Get the COVID-19 Vaccine If You Take Rituximab?
Treatment of rheumatoid arthritis with rituximab: An update and possible indications - ScienceDirect
